Natural Product ID:   | NPC195969 |
Common Name:   | Paromomycin |
IUPAC Name:   | (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol |
Synonyms:   | Aminosidine; Monomycin; Paromomycin |
Molecular Formula:   | C23H45N5O14 |
Standard InCHIKey:   | UOZODPSAJZTQNH-LSWIJEOBSA-N |
Standard InCHI:   | InChI=1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1 |
Canonical SMILES:   | OC[C@H]1O[C@H]([C@@H]([C@@H]1O[C@H]1O[C@@H](CN)[C@H]([C@@H]([C@H]1N)O)O)O)O[C@@H]1[C@@H](O)[C@H](N)C[C@@H]([C@H]1O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1N)O)O)N |
First Find Year:   | |
Max Developmental Stage:   | |
Synthetic Gene Cluster:   | BGC0000712 ; |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT317 | Uncleic Acid | Nucleic Acid | MIC | > | 100000 | nM | 9457241 | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 1640 | nM | 11814798 | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 1580 | nM | 11814798 | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 5330 | nM | 11814798 | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 1700 | nM | 11814798 | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 400 | nM | 11814798 | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 1000 | nM | 12951103 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 3000 | nM | 12951103 |
NPT2 | Others | Unspecified | MIC | = | 560 | nM | 12951103 | |
NPT2 | Others | Unspecified | Kd | = | 3830 | nM | 12127547 | |
NPT2 | Others | Unspecified | Kd | = | 440 | nM | 12127547 | |
NPT2 | Others | Unspecified | Kd | = | 12600 | nM | 12127547 | |
NPT2 | Others | Unspecified | Kd | = | 5850 | nM | 12127547 | |
NPT4383 | Uncleic Acid | Ribosomal RNA A-site | Kd | = | 200 | nM | 11206440 | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 3000 | nM | 14980669 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 6000 | nM | 14980669 |
NPT144 | Individual Protein | Telomerase reverse transcriptase | Homo sapiens | Inhibition | = | 60 | % | 15177454 |
NPT144 | Individual Protein | Telomerase reverse transcriptase | Homo sapiens | Inhibition | = | 29 | % | 15177454 |
NPT2 | Others | Unspecified | Inhibition | = | 0 | % | 15177454 | |
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | Kd | = | 50000 | nM | 15808490 |
NPT4383 | Uncleic Acid | Ribosomal RNA A-site | Kd | = | 100 | nM | 16168642 | |
NPT317 | Uncleic Acid | Nucleic Acid | IC50 | = | 600 | nM | 16168642 | |
NPT5110 | Organism | Meriones unguiculatus | Meriones unguiculatus | Activity | = | 14 | % | 16480281 |
NPT5110 | Organism | Meriones unguiculatus | Meriones unguiculatus | Activity | = | 17.6 | % | 16480281 |
NPT4383 | Uncleic Acid | Ribosomal RNA A-site | Kd | = | 390 | nM | 16942021 | |
NPT19 | Organism | Escherichia coli | Escherichia coli | Activity | = | 40 | % | 17088492 |
NPT19 | Organism | Escherichia coli | Escherichia coli | Activity | = | 70 | % | 17088492 |
NPT19 | Organism | Escherichia coli | Escherichia coli | Activity | = | 55 | % | 17088492 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 0.25 | ug/ml | 17088477 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 128 | ug/ml | 17088477 |
NPT1521 | Organism | Stenotrophomonas maltophilia | Stenotrophomonas maltophilia | MIC | = | 256 | ug/ml | 17088477 |
NPT1521 | Organism | Stenotrophomonas maltophilia | Stenotrophomonas maltophilia | MIC | = | 64 | ug/ml | 17088477 |
NPT2 | Others | Unspecified | MIC | = | 250 | ug/ml | 17060530 | |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 250 | ug/ml | 17060530 |
NPT2901 | Organism | Bifidobacterium thermophilum | Bifidobacterium thermophilum | MIC | = | 250 | ug/ml | 17060530 |
NPT2 | Others | Unspecified | MIC | = | 500 | ug/ml | 17060530 | |
NPT2 | Others | Unspecified | MIC | = | 125 | ug/ml | 17060530 | |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 500 | ug/ml | 17060530 |
NPT2901 | Organism | Bifidobacterium thermophilum | Bifidobacterium thermophilum | MIC | = | 500 | ug/ml | 17060530 |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 125 | ug/ml | 17060530 |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 62.5 | ug/ml | 17060530 |
NPT19 | Organism | Escherichia coli | Escherichia coli | Activity | = | 50 | % | 17088492 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 3 | ug/ml | 17458946 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 1 | ug/ml | 17458946 |
NPT2 | Others | Unspecified | Kd | = | 370 | nM | 17399988 | |
NPT2 | Others | Unspecified | Kd | = | 980 | nM | 17399988 | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 40 | % | 19309154 | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 1.62 | % | 19309154 | |
NPT71 | Cell Line | HEK293 | Homo sapiens | LC50 | = | 1200000 | nM | 19309154 |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | LC50 | = | 1500000 | nM | 19309154 |
NPT32 | Organism | Mus musculus | Mus musculus | LD50 | = | 80 | mg/kg | 19309154 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 22000 | nM | 19309154 |
NPT19 | Organism | Escherichia coli | Escherichia coli | IC50 | = | 56 | nM | 19309154 |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | < | 12000 | nM | 19445516 | |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 64 | ug/ml | 17875999 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 4 | ug/ml | 17875999 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 0.5 | ug/ml | 17875999 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 1 | ug/ml | 17875999 |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 2 | % | 19946275 | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 12 | % | 19946275 | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 63.9 | % | 19946275 | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 0.51 | /s | 19946275 | |
NPT2905 | Organism | Nocardia farcinica | Nocardia farcinica | MIC | > | 1024 | ug/ml | 20308368 |
NPT2905 | Organism | Nocardia farcinica | Nocardia farcinica | MIC | = | 8 | ug/ml | 20308368 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | > | 100000 | nM | 20368397 |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 25000 | nM | 20368397 |
NPT634 | Organism | Leishmania amazonensis | Leishmania amazonensis | IC50 | = | 19000 | nM | 20368397 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | > | 50000 | nM | 20368397 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 1 | ug/ml | 20970332 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 3 | ug/ml | 20970332 |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 0.1 | ug/ml | 19104019 |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 0.3 | ug/ml | 19104019 |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 0.8 | ug/ml | 19104019 |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 2 | ug/ml | 19104019 |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 3 | ug/ml | 19104019 |
NPT5112 | Individual Protein | 30S ribosomal protein S12 | Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) | Inhibition | = | 80 | % | 19104019 |
NPT2 | Others | Unspecified | Inhibition | > | 80 | % | 19104019 | |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | IC50 | = | 711 | nM | 18591280 |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | = | 95 | % | 18591280 |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | = | 96.4 | % | 18591280 |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | < | 2 | % | 18591280 |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Inhibition | = | 40 | % | 18591280 |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | > | 80 | % | 18591280 |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | = | 90 | % | 18591280 |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | = | 85 | % | 18591280 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | = | 123.92 | % | 21295472 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 24.79 | ug/ml | 21295472 |
NPT1182 | Cell Line | J774.A1 | Mus musculus | CC50 | = | 53.33 | ug/ml | 21295472 |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 2.15 | 21295472 | ||
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | = | 46.7 | % | 21295472 |
NPT841 | Organism | Leishmania major | Leishmania major | EC50 | = | 4290 | nM | 21199921 |
NPT841 | Organism | Leishmania major | Leishmania major | EC50 | = | 3980 | nM | 21199921 |
NPT841 | Organism | Leishmania major | Leishmania major | Ratio EC50 | = | 1 | 21199921 | |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | EC50 | = | 65000 | nM | 22310229 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 2 | ug/ml | 24900282 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 64 | ug/ml | 24900282 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | GI | = | 46.7 | % | 23031597 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 85500 | nM | 22989363 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 62600 | nM | 22989363 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 41000 | nM | 22989363 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 24500 | nM | 22989363 |
NPT2 | Others | Unspecified | Ratio IC50 | > | 4.1 | 22989363 | ||
NPT2 | Others | Unspecified | IC50 | > | 100000 | nM | 22989363 | |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | > | 100000 | nM | 22989363 |
NPT2 | Others | Unspecified | Ratio IC50 | > | 1.6 | 22989363 | ||
NPT2 | Others | Unspecified | Ratio IC50 | > | 1.2 | 22989363 | ||
NPT2 | Others | Unspecified | Ratio IC50 | > | 2.4 | 22989363 | ||
NPT2 | Others | Unspecified | MIC | > | 64 | ug/ml | 23602621 | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 64 | ug/ml | 23602621 |
NPT1228 | Organism | Streptococcus pyogenes | Streptococcus pyogenes | MIC | = | 64 | ug/ml | 23602621 |
NPT2 | Others | Unspecified | MIC | = | 64 | ug/ml | 23602621 | |
NPT2 | Others | Unspecified | MIC | = | 32 | ug/ml | 23602621 | |
NPT1228 | Organism | Streptococcus pyogenes | Streptococcus pyogenes | MIC | = | 16 | ug/ml | 23602621 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 16 | ug/ml | 23602621 |
NPT1277 | Organism | Staphylococcus epidermidis ATCC 12228 | Staphylococcus epidermidis ATCC 12228 | MIC | = | 2 | ug/ml | 23602621 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | = | 46 | % | 23673014 |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 2 | 23673014 | ||
NPT189 | Cell Line | Vero | Chlorocebus aethiops | CC50 | = | 53300 | nM | 23673014 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 24800 | nM | 23673014 |
NPT1466 | Organism | Escherichia coli K12 | Escherichia coli K-12 | MIC | = | 113 | ug/ml | 24457095 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 4 | ug/ml | 24457095 |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | = | 113 | ug/ml | 24457095 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 4 | ug/ml | 24457095 |
NPT2 | Others | Unspecified | IC50 | = | 10.42 | ug/ml | 10.1039/C4MD00119B | |
NPT2 | Others | Unspecified | IC50 | = | 0.03 | ug/ml | 10.1039/C4MD00119B | |
NPT2 | Others | Unspecified | IC50 | = | 0.57 | ug/ml | 10.1039/C4MD00119B | |
NPT2 | Others | Unspecified | IC50 | = | 0.26 | ug/ml | 10.1039/C4MD00119B | |
NPT2 | Others | Unspecified | IC50 | = | 50.54 | ug/ml | 10.1039/C4MD00119B | |
NPT2 | Others | Unspecified | IC50 | = | 5.83 | ug/ml | 10.1039/C4MD00119B | |
NPT2 | Others | Unspecified | IC50 | = | 10.39 | ug/ml | 10.1039/C4MD00119B | |
NPT2 | Others | Unspecified | IC50 | = | 9.78 | ug/ml | 10.1039/C4MD00119B | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 4 | ug/ml | 10.1039/C4MD00119B |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 256 | ug/ml | 10.1039/C4MD00119B |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 2 | ug/ml | 10.1039/C4MD00119B |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 16 | ug/ml | 10.1039/C4MD00119B |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 8 | ug/ml | 10.1039/C4MD00119B |
NPT2 | Others | Unspecified | Inhibition | = | 10 | % | 26264847 | |
NPT2 | Others | Unspecified | IC50 | = | 773000 | nM | 26264847 | |
NPT2 | Others | Unspecified | IC50 | = | 345000 | nM | 26264847 | |
NPT2 | Others | Unspecified | IC50 | = | 543000 | nM | 26264847 | |
NPT2 | Others | Unspecified | Kd | = | 138000 | nM | 26264847 | |
NPT2 | Others | Unspecified | Kd | = | 44000 | nM | 26264847 | |
NPT2 | Others | Unspecified | Kd | = | 91200 | nM | 26264847 | |
NPT2 | Others | Unspecified | Kd | = | 133200 | nM | 26264847 | |
NPT2 | Others | Unspecified | Ratio | = | 1 | 26264847 | ||
NPT2 | Others | Unspecified | Kd | = | 167000 | nM | 26264847 | |
NPT2 | Others | Unspecified | Ratio | = | 1.2 | 26264847 | ||
NPT2 | Others | Unspecified | Activity | = | 61 | % | 26264847 | |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | > | 100000 | nM | 26708110 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 4 | ug/ml | 10.1039/C5MD00429B |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 2 | ug/ml | 10.1039/C5MD00429B |
NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | MIC | = | 2 | ug/ml | 10.1039/C5MD00429B |
NPT747 | Organism | Acinetobacter baumannii | Acinetobacter baumannii | MIC | = | 4 | ug/ml | 10.1039/C5MD00429B |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | > | 64 | ug/ml | 10.1039/C5MD00429B |
NPT1033 | Organism | Enterobacter cloacae | Enterobacter cloacae | MIC | > | 64 | ug/ml | 10.1039/C5MD00429B |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | > | 64 | ug/ml | 10.1039/C5MD00429B |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 64 | ug/ml | 10.1039/C5MD00429B |
NPT747 | Organism | Acinetobacter baumannii | Acinetobacter baumannii | MIC | > | 64 | ug/ml | 10.1039/C5MD00429B |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 8 | ug/ml | 10.1039/C5MD00429B |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC195969 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC176381 |
0.9759 | High Similarity | NPC214376 |
0.9759 | High Similarity | NPC314408 |
0.9759 | High Similarity | NPC477060 |
0.9759 | High Similarity | NPC123746 |
0.9759 | High Similarity | NPC43850 |
0.9759 | High Similarity | NPC314007 |
0.9651 | High Similarity | NPC315334 |
0.9639 | High Similarity | NPC313552 |
0.9157 | High Similarity | NPC263058 |
0.9036 | High Similarity | NPC315969 |
0.9 | High Similarity | NPC330590 |
0.8617 | High Similarity | NPC315036 |
0.8571 | High Similarity | NPC318258 |
0.8421 | Intermediate Similarity | NPC471628 |
0.8421 | Intermediate Similarity | NPC56298 |
0.7864 | Intermediate Similarity | NPC57436 |
0.7864 | Intermediate Similarity | NPC121479 |
0.7717 | Intermediate Similarity | NPC306838 |
0.7624 | Intermediate Similarity | NPC221148 |
0.7447 | Intermediate Similarity | NPC470282 |
0.7416 | Intermediate Similarity | NPC316807 |
0.7349 | Intermediate Similarity | NPC322801 |
0.7349 | Intermediate Similarity | NPC129100 |
0.7349 | Intermediate Similarity | NPC291650 |
0.7333 | Intermediate Similarity | NPC70574 |
0.7333 | Intermediate Similarity | NPC100204 |
0.7333 | Intermediate Similarity | NPC83248 |
0.7315 | Intermediate Similarity | NPC241597 |
0.7283 | Intermediate Similarity | NPC165119 |
0.7222 | Intermediate Similarity | NPC98750 |
0.7174 | Intermediate Similarity | NPC36927 |
0.7174 | Intermediate Similarity | NPC271772 |
0.7105 | Intermediate Similarity | NPC94319 |
0.697 | Remote Similarity | NPC328646 |
0.6882 | Remote Similarity | NPC471420 |
0.6771 | Remote Similarity | NPC192025 |
0.6771 | Remote Similarity | NPC125253 |
0.6771 | Remote Similarity | NPC253975 |
0.6701 | Remote Similarity | NPC83839 |
0.6667 | Remote Similarity | NPC150557 |
0.6667 | Remote Similarity | NPC470284 |
0.6606 | Remote Similarity | NPC317534 |
0.6517 | Remote Similarity | NPC327486 |
0.6517 | Remote Similarity | NPC223174 |
0.6517 | Remote Similarity | NPC327753 |
0.6346 | Remote Similarity | NPC470283 |
0.6311 | Remote Similarity | NPC208537 |
0.6311 | Remote Similarity | NPC270005 |
0.631 | Remote Similarity | NPC34877 |
0.631 | Remote Similarity | NPC290179 |
0.6293 | Remote Similarity | NPC313813 |
0.625 | Remote Similarity | NPC20035 |
0.6211 | Remote Similarity | NPC314772 |
0.6211 | Remote Similarity | NPC314968 |
0.6161 | Remote Similarity | NPC59589 |
0.6147 | Remote Similarity | NPC188453 |
0.6147 | Remote Similarity | NPC42320 |
0.6118 | Remote Similarity | NPC317023 |
0.61 | Remote Similarity | NPC476523 |
0.6092 | Remote Similarity | NPC17455 |
0.6036 | Remote Similarity | NPC314413 |
0.6036 | Remote Similarity | NPC239705 |
0.6036 | Remote Similarity | NPC314398 |
0.6022 | Remote Similarity | NPC474468 |
0.6 | Remote Similarity | NPC244539 |
0.6 | Remote Similarity | NPC472025 |
0.5982 | Remote Similarity | NPC62845 |
0.5982 | Remote Similarity | NPC166242 |
0.5982 | Remote Similarity | NPC322449 |
0.5982 | Remote Similarity | NPC189854 |
0.5982 | Remote Similarity | NPC92874 |
0.5938 | Remote Similarity | NPC313762 |
0.5929 | Remote Similarity | NPC10897 |
0.5929 | Remote Similarity | NPC325900 |
0.5904 | Remote Similarity | NPC67660 |
0.5904 | Remote Similarity | NPC130683 |
0.5904 | Remote Similarity | NPC145112 |
0.5904 | Remote Similarity | NPC157514 |
0.5904 | Remote Similarity | NPC323361 |
0.5904 | Remote Similarity | NPC269166 |
0.5904 | Remote Similarity | NPC242073 |
0.5904 | Remote Similarity | NPC246558 |
0.5904 | Remote Similarity | NPC107914 |
0.5904 | Remote Similarity | NPC58629 |
0.5904 | Remote Similarity | NPC165198 |
0.5904 | Remote Similarity | NPC89145 |
0.5897 | Remote Similarity | NPC314306 |
0.5887 | Remote Similarity | NPC68327 |
0.5833 | Remote Similarity | NPC303727 |
0.5795 | Remote Similarity | NPC477757 |
0.5795 | Remote Similarity | NPC472026 |
0.5795 | Remote Similarity | NPC477755 |
0.5795 | Remote Similarity | NPC477763 |
0.5795 | Remote Similarity | NPC477750 |
0.5795 | Remote Similarity | NPC477762 |
0.5795 | Remote Similarity | NPC477753 |
0.5778 | Remote Similarity | NPC6848 |
0.5745 | Remote Similarity | NPC476694 |
0.5745 | Remote Similarity | NPC28959 |
0.5745 | Remote Similarity | NPC476695 |
0.5745 | Remote Similarity | NPC137554 |
0.5745 | Remote Similarity | NPC255535 |
0.5745 | Remote Similarity | NPC299603 |
0.5745 | Remote Similarity | NPC476696 |
0.5745 | Remote Similarity | NPC285014 |
0.5726 | Remote Similarity | NPC139857 |
0.5714 | Remote Similarity | NPC315980 |
0.5701 | Remote Similarity | NPC61894 |
0.5701 | Remote Similarity | NPC475603 |
0.5663 | Remote Similarity | NPC326533 |
0.5652 | Remote Similarity | NPC475918 |
0.5638 | Remote Similarity | NPC475694 |
0.5638 | Remote Similarity | NPC473710 |
0.5635 | Remote Similarity | NPC75839 |
0.5632 | Remote Similarity | NPC219040 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC195969 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD5795 | Approved |
1.0 | High Similarity | NPD5797 | Approved |
1.0 | High Similarity | NPD5794 | Approved |
1.0 | High Similarity | NPD5796 | Clinical (unspecified phase) |
1.0 | High Similarity | NPD5798 | Approved |
0.9759 | High Similarity | NPD3203 | Approved |
0.9759 | High Similarity | NPD3207 | Approved |
0.9759 | High Similarity | NPD3209 | Approved |
0.9759 | High Similarity | NPD2698 | Approved |
0.9759 | High Similarity | NPD3201 | Approved |
0.9759 | High Similarity | NPD3202 | Approved |
0.9759 | High Similarity | NPD3208 | Approved |
0.9639 | High Similarity | NPD3200 | Clinical (unspecified phase) |
0.9 | High Similarity | NPD5377 | Approved |
0.9 | High Similarity | NPD5381 | Approved |
0.9 | High Similarity | NPD5378 | Approved |
0.8602 | High Similarity | NPD4282 | Approved |
0.8421 | Intermediate Similarity | NPD4835 | Approved |
0.8421 | Intermediate Similarity | NPD4837 | Approved |
0.8421 | Intermediate Similarity | NPD4838 | Approved |
0.8421 | Intermediate Similarity | NPD4836 | Approved |
0.8182 | Intermediate Similarity | NPD5376 | Approved |
0.7864 | Intermediate Similarity | NPD35 | Approved |
0.7864 | Intermediate Similarity | NPD4833 | Approved |
0.7624 | Intermediate Similarity | NPD1450 | Approved |
0.7624 | Intermediate Similarity | NPD1449 | Approved |
0.7349 | Intermediate Similarity | NPD9033 | Approved |
0.7349 | Intermediate Similarity | NPD9030 | Approved |
0.7349 | Intermediate Similarity | NPD9031 | Approved |
0.7349 | Intermediate Similarity | NPD9032 | Approved |
0.7315 | Intermediate Similarity | NPD3731 | Phase 3 |
0.729 | Intermediate Similarity | NPD2690 | Discontinued |
0.7212 | Intermediate Similarity | NPD2700 | Approved |
0.72 | Intermediate Similarity | NPD6428 | Approved |
0.7182 | Intermediate Similarity | NPD4832 | Approved |
0.7182 | Intermediate Similarity | NPD4831 | Approved |
0.7182 | Intermediate Similarity | NPD4830 | Approved |
0.7105 | Intermediate Similarity | NPD4826 | Approved |
0.7105 | Intermediate Similarity | NPD4828 | Approved |
0.7105 | Intermediate Similarity | NPD4827 | Approved |
0.7045 | Intermediate Similarity | NPD67 | Phase 2 |
0.7045 | Intermediate Similarity | NPD9034 | Approved |
0.6957 | Remote Similarity | NPD6436 | Phase 3 |
0.6792 | Remote Similarity | NPD8045 | Clinical (unspecified phase) |
0.6637 | Remote Similarity | NPD3204 | Clinical (unspecified phase) |
0.66 | Remote Similarity | NPD3716 | Discontinued |
0.6517 | Remote Similarity | NPD9445 | Approved |
0.6486 | Remote Similarity | NPD6941 | Approved |
0.6476 | Remote Similarity | NPD881 | Approved |
0.6239 | Remote Similarity | NPD7141 | Clinical (unspecified phase) |
0.6239 | Remote Similarity | NPD7140 | Approved |
0.6239 | Remote Similarity | NPD7139 | Approved |
0.6211 | Remote Similarity | NPD9435 | Approved |
0.6211 | Remote Similarity | NPD9434 | Approved |
0.614 | Remote Similarity | NPD8087 | Discontinued |
0.6095 | Remote Similarity | NPD1447 | Phase 3 |
0.6095 | Remote Similarity | NPD1446 | Phase 3 |
0.6078 | Remote Similarity | NPD4759 | Clinical (unspecified phase) |
0.5977 | Remote Similarity | NPD6123 | Approved |
0.5963 | Remote Similarity | NPD2255 | Approved |
0.595 | Remote Similarity | NPD8346 | Approved |
0.595 | Remote Similarity | NPD8347 | Approved |
0.595 | Remote Similarity | NPD8345 | Approved |
0.5904 | Remote Similarity | NPD895 | Approved |
0.5904 | Remote Similarity | NPD892 | Phase 3 |
0.5904 | Remote Similarity | NPD893 | Approved |
0.5904 | Remote Similarity | NPD887 | Approved |
0.5904 | Remote Similarity | NPD890 | Clinical (unspecified phase) |
0.5904 | Remote Similarity | NPD891 | Phase 3 |
0.5904 | Remote Similarity | NPD889 | Approved |
0.5904 | Remote Similarity | NPD894 | Approved |
0.5904 | Remote Similarity | NPD888 | Phase 3 |
0.5897 | Remote Similarity | NPD6430 | Approved |
0.5897 | Remote Similarity | NPD6429 | Approved |
0.5826 | Remote Similarity | NPD8174 | Phase 2 |
0.5783 | Remote Similarity | NPD2269 | Approved |
0.5778 | Remote Similarity | NPD1457 | Discontinued |
0.5773 | Remote Similarity | NPD372 | Clinical (unspecified phase) |
0.576 | Remote Similarity | NPD591 | Approved |
0.576 | Remote Similarity | NPD577 | Phase 3 |
0.5739 | Remote Similarity | NPD8307 | Discontinued |
0.5728 | Remote Similarity | NPD394 | Phase 3 |
0.5663 | Remote Similarity | NPD905 | Approved |
0.5663 | Remote Similarity | NPD904 | Phase 3 |
0.5631 | Remote Similarity | NPD361 | Discontinued |
0.5625 | Remote Similarity | NPD389 | Phase 3 |
0.5603 | Remote Similarity | NPD8140 | Approved |
PubChem CID   | 165580 |
ChEMBL   | CHEMBL370143 |
ZINC   |
Molecular Weight:   | 615.30 |
ALogP:   | -9.0195 |
MLogP:   | 1.9 |
XLogP:   | -6.847 |
# Rotatable Bonds:   | 22 |
Polar Surface Area:   | 347.32 |
# H-Bond Aceptor:   | 19 |
# H-Bond Donor:   | 13 |
# Rings:   | 4 |
# Heavy Atoms:   | 42 |